UniProtKB/Swiss-Prot Q15848: Variant p.Arg221Ser

Adiponectin
Gene: ADIPOQ
Feedback?

Variant information Variant position:

221 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Serine (S) at position 221 (R221S, p.Arg221Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Genetic variations in ADIPOQ influence the variance in adiponectin serum levels and define the adiponectin serum levels quantitative trait locus 1 (ADIPQTL1) [MIM:612556]. Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs138773406 [ dbSNP | Ensembl ]

Sequence information Variant position:

221 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

244 The length of the canonical sequence.
Location on the sequence:

VLLHLEVGDQVWLQVYGEGE R NGLYADNDNDSTFTGFLLYH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VLLHLEVGDQVWLQVYGEGERNGLYADNDNDSTFTGFLLYH

Mouse                         VLLHLEVGDQVWLQVYGDGDHNGLYADNVNDSTFTGFLLYH

Bovine                        VLLYLEKGDQVWLQVYEGENHNGVYADNVNDSTFTGFLLYH

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 244	Adiponectin
Domain	108 – 244	C1q
Site	230 – 230	Not glycosylated

Literature citations
Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.
Hara K.; Boutin P.; Mori Y.; Tobe K.; Dina C.; Yasuda K.; Yamauchi T.; Otabe S.; Okada T.; Eto K.; Kadowaki H.; Hagura R.; Akanuma Y.; Yazaki Y.; Nagai R.; Taniyama M.; Matsubara K.; Yoda M.; Nakano Y.; Kimura S.; Tomita M.; Kimura S.; Ito C.; Froguel P.; Kadowaki T.;
Diabetes 51:536-540(2002)
Cited for: VARIANTS ARG-84; MET-117; THR-164; SER-221 AND PRO-241; INVOLVEMENT IN ADPOD; Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome.
Kondo H.; Shimomura I.; Matsukawa Y.; Kumada M.; Takahashi M.; Matsuda M.; Ouchi N.; Kihara S.; Kawamoto T.; Sumitsuji S.; Funahashi T.; Matsuzawa Y.;
Diabetes 51:2325-2328(2002)
Cited for: VARIANTS SER-221 AND PRO-241; POLYMORPHISM; VARIANTS ADPOD CYS-112 AND THR-164;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.